Clinical Trial

Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke

Study acronym: PIONEER
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 6, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary purpose of this study is to investigate the effectiveness of Ginkgo Diterpene Lactone Meglumine (GDLM) for patients with acute ischemic stroke (AIS) in real-world settings.
Trial Details
NCT Number NCT06861426
Lead Sponsor Ying Gao
Conditions Acute Ischemic Stroke
Enrollment 4,460 participants
Start Date 2025-03-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-06